« Back to Record
Baselga, J., Haddad, T., Ciruelos Gil, E. M., Vuylsteke, P., Ebbinghaus, S., Im, E., Eaton, L., Pathiraja, K., Gause, C., Mauro, D., Jones, M. B., Morales, S., Rugo, H., Awada, A., Blum, J. J., Tan, A. R., Ewertz, M., Cortes, J., Moy, B., & Ruddy, K. K. (2017). A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Breast cancer research and treatment, 163(3), 535-544. doi:10.1007/s10549-017-4199-3
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253468



